|
HIATL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.224500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.576400E-03 |
| Normal-vs-Stage2 |
1.776200E-03 |
| Normal-vs-Stage3 |
4.404900E-04 |
| Normal-vs-Stage4 |
1.52807999999061E-05 |
| Stage1-vs-Stage2 |
8.297900E-02 |
| Stage1-vs-Stage3 |
7.982000E-02 |
| Stage1-vs-Stage4 |
7.117700E-03 |
| Stage2-vs-Stage3 |
7.053800E-01 |
| Stage2-vs-Stage4 |
5.018600E-01 |
| Stage3-vs-Stage4 |
2.379200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.964500E-04 |
| Normal-vs-AfricanAmerican |
3.077600E-02 |
| Normal-vs-Asian |
2.583400E-01 |
| Caucasian-vs-AfricanAmerican |
9.237000E-01 |
| Caucasian-vs-Asian |
1.572820E-01 |
| AfricanAmerican-vs-Asian |
3.423200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.192300E-04 |
| Normal-vs-Female |
1.102100E-03 |
| Male-vs-Female |
2.381600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.629600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.61449999999919E-05 |
| Normal-vs-Age(61-80Yrs) |
9.57940000000379E-05 |
| Normal-vs-Age(81-100Yrs) |
1.297960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.772180E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.780200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.526630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.122000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.827800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.955600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.152400E-01 |
| Classical-VS-Follicular |
4.102400E-03 |
| Classical-VS-Other |
4.770600E-01 |
| Classical-VS-Normal |
3.773500E-02 |
| Tall-VS-Follicular |
7.961000E-01 |
| Tall-VS-Other |
9.235000E-01 |
| Tall-VS-Normal |
5.122200E-03 |
| Follicular-VS-Other |
8.108000E-01 |
| Follicular-VS-Normal |
2.593100E-04 |
| Other-VS-Normal |
1.028550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.972760E-04 |
| Normal-vs-N1 |
9.780700E-03 |
| N0-vs-N1 |
9.626000E-01 |
|
|
